Sponsor:
Rhaeos, Inc.
Code:
NCT07815314
Conditions
Hydrocephalus
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Interventions
Rhaeos Shunt Monitoring System (RSMS)
ShuntCheck III
Brief summary:
Conditions
Hydrocephalus
Study ID
NCT07815314
Start date
Sep 23, 2026
Status verified date
Nov, 2026
Completion date
Feb, 2027
Anticipated
Primary completion date
Jan, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
85 participants
Anticipated
Intervention Model
Single group
Primary purpose
Screening
Arms
other: Participants Undergoing Paired CSF Shunt Flow Assessment
Interventions
Rhaeos Shunt Monitoring System (RSMS)
ShuntCheck III
Primary outcome measure
Central contacts
Locations
Northwestern Medical Group
Recruiting
Chicago, Illinois, United States, 60611
Contacts
Principal Investigator:
Matthew Tate, MD PhD
Rhaeos, Inc
Recruiting
Chicago, Illinois, United States, 60642
Contacts
The Johns Hopkins Hospital
Recruiting
Baltimore, Maryland, United States, 21287
Principal Investigator:
Mark G Luciano, MD PhD
Comprehensive Neurosurgery Center
Recruiting
Williamsville, New York, United States, 14221
Contacts
Principal Investigator:
Jason Davies, MD PhD
Sponsor
Rhaeos, Inc.
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Rhaeos, Inc. on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.